Toxys
Business Services · Netherlands · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7 De Limes, Oegstgeest, South Holland, 2...Phone Number
+31 713322470Website
www.toxys.comRevenue
<$5 MillionIndustry
About Toxys
Is Toxys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Toxys
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Toxys had a recent Job posting/layoffs
Product Launch: Get notified when Toxys launches new products
Check if Toxys has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Toxys recently announced quarterly report
Toxys, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Toxys is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Toxys has new funding data
Recommended Actions
Reach out to Masked Content who joined Toxys as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Toxys is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Toxys is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Toxys.
Toxys financials insights
Gather financial insights about Toxys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$1.6M
Toxys Tech Stack
A closer look at the technologies used by Toxys
Toxys News & Media
Animal-free safety testing of novel medicines, chemicals, and consumer products - chemeurope.com
Toxys BV, a Dutch biotech company that offers a broad spectrum of innovative in vitro toxicology solutions for the safety assessment of novel medicines, (agro)chemicals, cosmetics, and food ingred ...Toxys Raises €2M in Funding
Toxys, a Leiden, The Netherlands-based biotech company, raised €2m in funding. Backers included KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank. The company intends to use the funds to expand its operations in Europe and the United States, to further broaden its portfolio of in vitro toxicology assays, speed-up international growth and work […] The post Toxys Raises €2M in Funding appeared first on FinSMEs.Charles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North America
Charles River will offer access to ToxTracker®, expanding the Company’s portfolio of genetic toxicology assays WILMINGTON, Mass. & LEIDEN, The Netherlands--(BUSINESS WIRE)--Jan. 30, 2019-- Charles River Laboratories International, Inc (NYSE: CRL) and Toxys have entered into an agreement to offer access to ToxTracker® in North America. ToxTracker is a suite of assays that allow rapid carcinogenicity toxicity hazard identification in novel and existing drugs, chemicals, and other substances. ThisCharles River Laboratories and Toxys Enter Agreement to Offer ToxTracker® in North America
WILMINGTON, Mass. & LEIDEN, The Netherlands--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24CRL&src=ctag" target="_blank"gt;$CRLlt;/agt; lt;a href="https://twitter.com/hashtag/LIFEatCRL?src=hash" target="_blank"gt;#LIFEatCRLlt;/agt;--Charles River and Toxys have entered into an agreement to offer access to ToxTracker® in North America.
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Toxys
Toxys is a Dutch biotech company specializing in innovative in vitro toxicity screening solutions aimed at identifying hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development. Their services include a range of unique assays such as ToxTracker and ReproTracker, which provide mechanis... Read More